The Indian Journal of Pediatrics

, Volume 86, Issue 3, pp 245–249 | Cite as

Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital

  • A. P. PoornimaEmail author
  • Shiffi Fazal
  • P. S. Shaiji
  • K. C. Usha
  • Lalitha Kailas
Original Article



To estimate the prevalence and specificity pattern of red blood cell (RBC) alloimmunization among pediatric multitransfused patients, and to identify the factors associated with alloimmunization.


This was a descriptive cross-sectional study conducted among mutitransfused pediatric patients over a period of two years. The relevant clinical details of patients were collected, and RBC antibody screening was done. Samples with positive antibody screen were subjected to antibody identification. Patient factors were analysed to find any significant relation to the development of RBC alloimmunization.


Alloantibodies were obtained in 4 (6.35%) of the total 63 patients, and autoantibody in 1 (1.59%). The specificities of alloantibodies identified were all against Rh antigens-one each of anti E, anti c, anti Cw and anti D + anti C. A significant association was seen between development of alloimmunization and first transfusion at more than 2 y of age.


RBC alloimmunization against Rhesus (Rh) antigens is a significant problem for multitransfused children in our population. Extended RBC phenotyping at least for antigens of the Rh system and provision of antigen matched RBCs may be an option for such children, where ongoing transfusion requirement is anticipated.


RBC alloimmunization Alloantibodies Pediatric population Multitransfused 



AP was the principal investigator. SF helped in data collection, testing and analysis of results. SPS contributed to the analysis and interpretation of data. UKC reviewed the study and suggested modifications. LK reviewed the final study and gave inputs. Dr. AP Poornima and Dr. Shaiji PS will act as guarantors for this article.

Compliance with Ethical Standards

Written informed consent was obtained from the guardians of the children in the study and Institutional Ethical Committee clearance was also obtained.

Conflict of Interest


Source of Funding



  1. 1.
    Sirchia G, Zanella A, Parravicini A, Morelati F, Rebulla P, Masera G. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985;25:110–2.CrossRefGoogle Scholar
  2. 2.
    Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang. 1990;58:50–5.Google Scholar
  3. 3.
    Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369–73.Google Scholar
  4. 4.
    Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion. 2003;43:1604–10.CrossRefGoogle Scholar
  5. 5.
    Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med. 2006;16:200–3.CrossRefGoogle Scholar
  6. 6.
    Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology. 2010;15:174–7.CrossRefGoogle Scholar
  7. 7.
    Thompson AA, Cunningham MJ, Singer ST, et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011;153:121–8.CrossRefGoogle Scholar
  8. 8.
    Gupta R, Singh DK, Singh B, Rusia U. Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci. 2011;45:167–70.CrossRefGoogle Scholar
  9. 9.
    Pradhan V, Badakere S, Vasantha K, Korgaonkar S, Panjwani S, Jajoo N. Antibodies to red cells in beta thalassemia major patients receiving multiple transfusions: a short report. Indian J Hematol Blood Transfus. 2001;19:100–1.Google Scholar
  10. 10.
    Jain R, Choudhury N, Chudgar U, et al. Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: a prospective study. Indian J Hematol Blood Transfus. 2014;30:291–6.CrossRefGoogle Scholar
  11. 11.
    Dhawan HK, Kumawat V, Marwaha N, et al. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci. 2014;8:84–8.CrossRefGoogle Scholar
  12. 12.
    Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol. 2001;113:661–5.CrossRefGoogle Scholar
  13. 13.
    Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34:562–9.CrossRefGoogle Scholar
  14. 14.
    Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion. 1997;37:357–61.CrossRefGoogle Scholar
  15. 15.
    Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94–8.CrossRefGoogle Scholar
  16. 16.
    Sakhalkar VS, Roberts K, Hawthorne LM, et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci. 2005;1054:495–9.CrossRefGoogle Scholar
  17. 17.
    Ameen R, Al Shemmari S, Al-Bashir A. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion. 2009;49:1649–54.CrossRefGoogle Scholar
  18. 18.
    Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briët E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007;47:2066–71.CrossRefGoogle Scholar
  19. 19.
    Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood. 1990;76:1431–7.Google Scholar
  20. 20.
    Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990;30:532–5.CrossRefGoogle Scholar
  21. 21.
    Charache S. Problems in transfusion therapy. N Engl J Med. 1990;322:1666–8.CrossRefGoogle Scholar
  22. 22.
    Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21:58–71.CrossRefGoogle Scholar
  23. 23.
    Blumberg N, Peck K, Ross K, Avila E. Immune response to chronic red blood cell transfusion. Vox Sang. 1983;44:212–7.CrossRefGoogle Scholar
  24. 24.
    Reisner EG, Kostyu DD, Phillips G, Walker C, Dawson DV. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens. 1987;30:161–6.CrossRefGoogle Scholar
  25. 25.
    Saied DA, Kaddah AM, Badr Eldin RM, Mohaseb SS. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Pediatr Hematol Oncol. 2011;33:409–14.CrossRefGoogle Scholar
  26. 26.
    Thuret I, Pondarré C, Loundou A, et al. Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica. 2010;95:724–9.CrossRefGoogle Scholar
  27. 27.
    Datta SS, Mukherjee S, Talukder B, Bhattacharya P, Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from eastern India. Adv Hematol. 2015;2015:610931.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of Transfusion MedicineGovernment Medical CollegeThiruvananthapuramIndia
  2. 2.Department of PediatricsGovernment Medical CollegeThiruvananthapuramIndia

Personalised recommendations